Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Executive or director change
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 8-K Event Regulation FD disclosure · Other events
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. EFFECT Other Notice of Effectiveness
  10. 424B3 Offering Prospectus
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 5 of 19 · 362 filings